Q&A: Covance's Tom Turi on the Rise of Sequencing in Drug Discovery and Development
March 29, 2011
Q&A: Covance's Tom Turi on the Rise of Sequencing in Drug Discovery and Development
Turi recently spoke with Clinical Sequencing News about Covance Genomics Laboratory's next-gen sequencing expertise and services.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Baylor, Texas Children's Hospital Aim to Make Sequencing Routine with New Pediatric Center
August 3, 2011 / Clinical Sequencing News - Illumina Books Orders for More than 135 MiSeqs, Starts Early-Access Shipments
August 2, 2011 / In Sequence - Q&A: Life Tech CMO Paul Billings on Moving Next-Gen Sequencing from the Bench to the Bedside
July 13, 2011 / Clinical Sequencing News - Partners Healthcare to Move Cardiomyopathy Genetic Test from Microarray to Illumina HiSeq
May 11, 2011 / Clinical Sequencing News - Illumina to Apply Rare-Cell Capture to Ovarian Cancer Program; Expects Clinical Apps for MiSeq
May 4, 2011 / Clinical Sequencing News